- Report
- February 2026
- 250 Pages
Global
From €4088EUR$4,490USD£3,522GBP
- Report
- July 2025
- 150 Pages
Global
From €5418EUR$5,950USD£4,668GBP
- Report
- February 2026
- 250 Pages
Global
From €4088EUR$4,490USD£3,522GBP
- Report
- January 2026
- 185 Pages
Global
From €4098EUR$4,500USD£3,530GBP
- Report
- December 2025
- 200 Pages
Global
From €7239EUR$7,950USD£6,237GBP
- Report
- June 2025
- 400 Pages
Global
From €4506EUR$4,949USD£3,882GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €3278EUR$3,600USD£2,824GBP
- Report
- August 2024
- 150 Pages
Global
From €3415EUR$3,750USD£2,942GBP
- Report
- June 2025
- 250 Pages
Canada
From €2540EUR$2,789USD£2,188GBP
- Report
- May 2023
- 160 Pages
Global
From €4506EUR$4,949USD£3,882GBP
- Report
- May 2024
- 129 Pages
Global
From €3641EUR$3,999USD£3,137GBP
- Report
- May 2025
- 106 Pages
Global
From €4325EUR$4,750USD£3,726GBP
- Report
- February 2024
- 181 Pages
Europe
From €4325EUR$4,750USD£3,726GBP
- Report
- February 2024
- 143 Pages
Global
From €4325EUR$4,750USD£3,726GBP
- Report
- February 2024
- 70 Pages
New Zealand
From €4325EUR$4,750USD£3,726GBP
- Report
- February 2024
- 80 Pages
Europe
From €4325EUR$4,750USD£3,726GBP
- Report
- February 2024
- 70 Pages
Germany
From €4325EUR$4,750USD£3,726GBP
- Report
- February 2024
- 70 Pages
Italy
From €4325EUR$4,750USD£3,726GBP
- Report
- February 2024
- 70 Pages
Oman
From €4325EUR$4,750USD£3,726GBP
- Report
- February 2024
- 70 Pages
Egypt
From €4325EUR$4,750USD£3,726GBP

Humalog is a brand of insulin used to treat diabetes, a chronic endocrine and metabolic disorder. It is a fast-acting insulin that helps to control blood sugar levels in people with type 1 and type 2 diabetes. Humalog is a recombinant human insulin analog, meaning it is a synthetic version of the natural human insulin. It is administered via injection and works by helping the body to use glucose from the bloodstream. Humalog is used to help control blood sugar levels in people with diabetes, and can be used in combination with other diabetes medications.
Humalog is available in a variety of forms, including vials, pens, and cartridges. It is manufactured by Eli Lilly and Company, and is available in many countries around the world. Other companies that produce insulin analogs include Novo Nordisk, Sanofi, and Biocon. Show Less Read more